NA Ashour, A Abo Elmaaty, AA Sarhan… - Drug design …, 2023 - Taylor & Francis
… available oralanti-SARS-CoV-2 candidates, as a new hope to end the current pandemic. … , on the other hand, assessed inhaled ribavirin preparation as a sole agent. Citation100 …
P Pagliano, C Sellitto, T Ascione… - Expert Opinion on …, 2022 - Taylor & Francis
… Molnupiravir (MOV) is a broad-spectrum oral antiviral agent … Molnupiravir for oral treatment of covid-19 in nonhospitalized … and safety of three neworal antiviral treatment (molnupiravir, …
L Tian, Z Pang, M Li, F Lou, X An, S Zhu… - Frontiers in …, 2022 - frontiersin.org
… or other antiviral biological agents such as convalescent … developed a new strategy to synthesize molnupiravir using … partly explain why the anti-SARS-CoV-2 activity of remdesivir in …
… drug–transporter interactions of Molnupiravir, Nirmatrelvir, and … In the case of the nucleoside analog Molnupiravir, we included … side effects of these widely used anti-COVID-19 agents. …
S Khiali, E Khani, SB Rouy… - Future Microbiology, 2022 - Taylor & Francis
… oral antiviral agents are still lacking. In the present review, the potential beneficial effects of molnupiravir in … be considered as disadvantages of anti-SARS-CoV-2 monoclonal antibodies. …
S Singla, S Goyal - Bulletin of the National Research Centre, 2022 - Springer
… Anti-SARS-CoV-2 treatment for patients with a suspected or confirmed COVID-19 infection … In this study, NHC was described as a potent anti-VEEV agent, with an EC50 below 1 μM and …
… It is rapidly converted into its active form after oral … on molnupiravir, a nucleoside prodrug, and its active metabolites, which exhibit promise as broad-spectrum anti-SARS-CoV-2agents …
E Zarenezhad, M Marzi - Medicinal Chemistry Research, 2022 - Springer
… Merck and Ridgeback Bio collaborate to develop of a new … new synthetic pathway of molnupiravir as an anti-viral agent to … -2, molnupiravir has shown strong anti-SARS-CoV-2 activity …
P Sendi, RR Razonable, SB Nelson, A Soriano… - Clinical Microbiology …, 2022 - Elsevier
… molnupiravir), and compliance with ingestion of a high number of pills. Knowledge gaps include the efficacy of these agents … , anti-SARS-CoV-2 monoclonal antibody plus oral antivirals) …